Barbanti, Piero
Egeo, Gabriella
Doretti, Alberto
Pistoia, Francesca
Rinalduzzi, Steno
Strumia, Silvia
Aurilia, Cinzia
Scatena, Paola
Autunno, Massimo
Salerno, Antonio
Galli, Alberto
Altavilla, Riccardo
Messina, Stefano
Zanferrari, Carla
Bruno, Pietrantonio
Camarda, Cecilia
D’Onofrio, Florindo
Iovene, Veronica
Ranieri, Angelo
Bono, Francesco
de Souza, Jesuély Spieckert
Carnevale, Antonio
Di Clemente, Laura
Zucco, Maurizio
Bandettini Di Poggio, Monica Laura
Vinciguerra, Luisa
Borrello, Laura
Fiorentini, Giulia
Vecchio, Rosario
Drago, Valeria
Torelli, Paola
Albanese, Maria
Tomino, Carlo
Bonassi, Stefano
Porreca, Annamaria
,
Aguggia, Marco
Alfieri, Gennaro
Alivernini, Diletta
Ardau, Raffaella
Bartolozzi, Maria Letizia
Bloise, Maria Carmela
Braca, Simone
Bruno, Antonio
Caproni, Stefano
Cetta, Ilaria
Cherchi, Alessandra
Colombo, Bruno
Colombo, Eleonora
Coppola, Alfonso
Cosenza, Domenico
Cortese, Francesca
Bartolo, Matteo De
De Simone, Roberto
Deidda, Arianna
Bene, Alessandra Del
Gallo, Giulia
Summa, Vittoria Carla D’Agostino Alfonsina
Favoni, Valentina
Ferraù, Ludovica
Pestalozza, Isabella Ferdinanda
Finocchi, Cinzia
Gai, Annalisa
Grugno, Rosario
Guarinoni, Martina
Iannaccone, Elisabetta
Idone, Giovanni
Laterza, Vincenzo
Presti, Riccardo Lo
Lombardi, Luca
Madonia, Irene
Mancioli, Andrea
Matignaro, Sara
Nizzoli, Silvia
Paolucci, Matteo
Piccininni, Maristella
Querzani, Pietro
Frediani, Fabio
Quintana, Simone
Robotti, Micaela
Rosettani, Pamela
Russo, Marco
Salvemini, Sergio
Sette, Giuliano
Spalloni, Alessandra
Sixt, Gabriele
Sforza, Michela
Cocuzza, Alessandro
Spano, Giorgio
Stochino, Maria Erminia
Tedeschi, Denise
Terlizzi, Rossana
Teresi, Valentina
Ungaro, Daniela
Valguarnera, Fabio
Vita, Gianluca
Zanandrea, Laura
Baiamonte, Liliana
Bozzo, Giulia
Article History
Received: 20 December 2025
Accepted: 10 January 2026
First Online: 31 January 2026
Declarations
:
: Not applicable
: Piero Barbanti received travel grants, honoraria for advisory boards, speaker panels or clinical investigation studies from Abbvie, Alder, Amgen, Angelini, Assosalute, Bayer, Biohaven, DOC Pharma, Eli-Lilly, Fondazione Ricerca e Salute, GSK, Lundbeck, Lusofarmaco, Noema Pharma, Novartis, Organon, Orion Pharma, Pfizer, Teva, Viatris, Visufarma, Zambon and serves as President with Italian Association of Headache Sufferers. Gabriella Egeo received travel grants and honoraria from Eli-Lilly, Novartis, TEVA, Lundbeck, New Penta and Ecupharma Alberto Doretti received travel grants and honoraria received travel grants and honoraria from Eli Lilly, Zambon, Teva, Abbvie, Neopharmed Gentili, and Lundbeck. Cinzia Aurilia received travel grants from Eli-Lilly, FB-Health, Lusofarmaco and Teva, honoraria from Novartis and Teva. Florindo d’Onofrio has received fees for participation on advisory boards, speaker honoraria or consulting activities from Angelini, Cristalfarma, Ecupharma, IBSA, Lundbeck, Novartis, PIAM, Teva Angelo Ranieri received honoraria for speaker activities, advisory boards, consulting, editorial contribution and travel grants from Novartis, Teva, Eli-Lilly, VyvaMed Srl, CPM Srl, CTP SrlK link srl, Lundbeck, AIM Education Srl, Momento Medico Srl. Francesco Bono received honoraria as a speaker or for participating in advisory boards from Teva, Novartis, Q1Q2Q3Ipsen Maurizio Zucco received travel grants and honoraria from Novartis Paola Torelli received travel grant, honoraria as a speaker, or for participating in advisory boards from Novartis, Teva, Eli Lilly, and Allergan. Maria Albanese received travel grants and honoraria from Novartis, Teva, Eli-Lilly and Lundbeck Francesca Pistoia, Steno Rinalduzzi, Silvia Strumia, Paola Scatena, Massimo Autunno, Antonio Salerno, Alberto Galli, Riccardo Altavilla, Stefano Messina, Carla Zanferrari, Pietrantonio Bruno, Cecilia Camarda, Veronica Iovine, Jesuély Spieckert de Souza, Antonio Carnevale, Laura Di Clemente, Monica Laura Bandettini Di Poggio, Luisa Vinciguerra, Laura Borrello, Giulia Fiorentini, Rosario Vecchio, Valeria Drago, Carlo Tomino, Stefano Bonassi and Annamaria Porreca have no disclosures to declare.